Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $94.6 million versus the consensus estimate of $93.7 million.

Natus Medical sees Q4 2015 EPS of $0.47-$0.49, versus the consensus of $0.48. Natus Medical sees Q4 2015 revenue of $102-105 million, versus the consensus of $101.7 million.

Natus Medical sees FY2015 EPS of $1.51-$1.53, versus the consensus of $1.51. Natus Medical sees FY2015 revenue of $376-378 million, versus the consensus of $377.8 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.